BAP1, a known tumor suppressor, is one such candidate biomarker that is mutated or deleted in a significant fraction of malignant mesothelioma (60%–70%) as well as in other cancers such as uveal melanoma (43%) and renal cell carcinoma (23%).3 Here, BAP1 is linked to neoplasm.